However, Elias et al. reported hypermethylation (epigenetic silencing) of the promoter DR4 in 60% of diffuse grade II astrocytomas, in 75% of anaplastic astrocytomas, and in 70% of GBM [73]. Here, TNFRSF10A is linked to glioblastoma.